Home/Filings/4/0001724521-25-000046
4//SEC Filing

KANEKO YASUNORI 4

Accession 0001724521-25-000046

CIK 0001724521other

Filed

Feb 26, 7:00 PM ET

Accepted

Feb 27, 7:06 PM ET

Size

7.3 KB

Accession

0001724521-25-000046

Insider Transaction Report

Form 4
Period: 2025-02-27
Transactions
  • Purchase

    Common Stock

    2025-02-27$10.06/sh+20,000$201,20028,400 total
Holdings
  • Common Stock

    (indirect: By LLC)
    252,524
  • Common Stock

    (indirect: By Trust)
    152,981
  • Common Stock

    (indirect: By LLC)
    505,050
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.00 to $10.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
  • [F2]Includes 6,800 shares of restricted stock units (previously reported) that vested on June 6, 2024 and were subsequently transferred to the reporting person's trust.

Issuer

Arcus Biosciences, Inc.

CIK 0001724521

Entity typeother

Related Parties

1
  • filerCIK 0001277503

Filing Metadata

Form type
4
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 7:06 PM ET
Size
7.3 KB